Deal Making

Featured on Deal Making

Synaffix strikes ADC licensing deal with Sotio
Deal-Making
Synaffix strikes ADC licensing deal with SotioSynaffix strikes ADC licensing deal with Sotio

Sotio will use Synaffix’s antibody-drug conjugate (ADC) platform to develop up to three products targeting tumor-associated antigens.

byMillie Nelson
Oct 18, 2023
|
2 Min Read
Cellevate garners seed funding for bioreactor tech
Deal-Making
Cellevate garners seed funding for bioreactor techCellevate garners seed funding for bioreactor tech
byShreeyashi Ojha
Oct 13, 2023
2 Min Read
Telethon accesses RetroNectin from Takara to support gene therapies
Deal-Making
Telethon accesses RetroNectin from Takara to support gene therapiesTelethon accesses RetroNectin from Takara to support gene therapies
byShreeyashi Ojha
Oct 12, 2023
1 Min Read
GSK inks $3bn partnership to market Shingrix in China
Deal-Making
GSK inks $3bn partnership to market Shingrix in ChinaGSK inks $3bn partnership to market Shingrix in China
byMillie Nelson
Oct 10, 2023
2 Min Read
Sharp bolsters fill/finish services with Berkshire buy
Deal-Making
Sharp bolsters fill/finish services with Berkshire buySharp bolsters fill/finish services with Berkshire buy
byMillie Nelson
Oct 9, 2023
2 Min Read
Biovectra to undertake tech transfer for Acuitas LNP platform
Deal-Making
Biovectra to undertake tech transfer for Acuitas LNP platformBiovectra to undertake tech transfer for Acuitas LNP platform
byMillie Nelson
Oct 9, 2023
2 Min Read

More from Deal Making

Lonza expanding capacity in Switzerland for ADC client
Deal-Making
Lonza expanding capacity in Switzerland for ADC client
Lonza expanding capacity in Switzerland for ADC client
Oct 6, 2023
|
1 Min Read
byShreeyashi Ojha
Resilience in risk-sharing gene therapy partnership with BridgeBio
Deal-Making
Resilience in risk-sharing gene therapy partnership with BridgeBio
Resilience in risk-sharing gene therapy partnership with BridgeBio
Oct 6, 2023
|
2 Min Read
byShreeyashi Ojha
GigaGen teams with NCI to develop oncology drug candidate
Deal-Making
GigaGen teams with NCI to develop oncology drug candidate
GigaGen teams with NCI to develop oncology drug candidate
Oct 6, 2023
|
2 Min Read
byMillie Nelson
Kyowa goes big on Libmeldy with $477m Orchard buy
Deal-Making
Kyowa goes big on Libmeldy with $477m Orchard buy
Kyowa goes big on Libmeldy with $477m Orchard buy
Oct 5, 2023
|
3 Min Read
byMillie Nelson
GeoVax licenses suspension cell line tech for vax portfolio
Deal-Making
GeoVax licenses suspension cell line tech for vax portfolio
GeoVax licenses suspension cell line tech for vax portfolio
Oct 2, 2023
|
2 Min Read
byMillie Nelson
Ginkgo inks RNA deal with Pfizer worth a potential $331m
Deal-Making
Ginkgo inks RNA deal with Pfizer worth a potential $331m
Ginkgo inks RNA deal with Pfizer worth a potential $331m
Sep 29, 2023
|
2 Min Read
byMillie Nelson
Kyverna and ElevateBio team to advance CAR-T platform
Deal-Making
Kyverna and ElevateBio team to advance CAR-T platform
Kyverna and ElevateBio team to advance CAR-T platform
Sep 27, 2023
|
2 Min Read
byMillie Nelson
Otsuka takes Shape to develop ocular gene therapies
Deal-Making
Otsuka takes Shape to develop ocular gene therapies
Otsuka takes Shape to develop ocular gene therapies
Sep 26, 2023
|
2 Min Read
bySara Healy
Oxford Biomedica to bolster viral vector capacity with ABL Europe buy
Deal-Making
Oxford Biomedica to bolster viral vector capacity with ABL Europe buy
Oxford Biomedica to bolster viral vector capacity with ABL Europe buy
Sep 25, 2023
|
2 Min Read
byDan Stanton
PackGene and KudoBio team on mRNA CDMO services
Deal-Making
PackGene and KudoBio team on mRNA CDMO services
PackGene and KudoBio team on mRNA CDMO services
Sep 22, 2023
|
2 Min Read
byDan Stanton
CancerVax teams with UCLA to develop universal CAR-T platform
Deal-Making
CancerVax teams with UCLA to develop universal CAR-T platform
CancerVax teams with UCLA to develop universal CAR-T platform
Sep 18, 2023
|
2 Min Read
byMillie Nelson
BWB 2023: Timelines, tech, trust critical to CDMO management success
Bioprocess Insider
BWB 2023: Timelines, tech, trust critical to CDMO management success
BWB 2023: Timelines, tech, trust critical to CDMO management success
Sep 18, 2023
|
3 Min Read
byDan Stanton
Samsung Biologics invests and partners with Korean ADC firm
Deal-Making
Samsung Biologics invests and partners with Korean ADC firm
Samsung Biologics invests and partners with Korean ADC firm
Sep 18, 2023
|
2 Min Read
byMillie Nelson
Moderna, Immatics ink $120m cancer-focused partnership
Deal-Making
Moderna, Immatics ink $120m cancer-focused partnership
Moderna, Immatics ink $120m cancer-focused partnership
Sep 13, 2023
|
2 Min Read
byMillie Nelson
AcuraBio winds up CDMO business a year after PE takeover
Deal-Making
AcuraBio winds up CDMO business a year after PE takeover
AcuraBio winds up CDMO business a year after PE takeover
Sep 12, 2023
|
1 Min Read
byDan Stanton
TherageniX and UK Uni team to develop powdered gene therapy
Deal-Making
TherageniX and UK Uni team to develop powdered gene therapy
TherageniX and UK Uni team to develop powdered gene therapy
Sep 11, 2023
|
2 Min Read
byMillie Nelson
eXmoor and Kincell team to meet CGT demand
Deal-Making
eXmoor and Kincell team to meet CGT demand
eXmoor and Kincell team to meet CGT demand
Sep 5, 2023
|
2 Min Read
byMillie Nelson
Gingko heads into the Cloud for AI drug development
Deal-Making
Gingko heads into the Cloud for AI drug development
Gingko heads into the Cloud for AI drug development
Sep 1, 2023
|
2 Min Read
byDan Stanton
Cabaletta eyes commercialization through WuXi ATU expansion
Deal-Making
Cabaletta eyes commercialization through WuXi ATU expansion
Cabaletta eyes commercialization through WuXi ATU expansion
Aug 30, 2023
|
2 Min Read
byMillie Nelson
HHS awards $1.4bn to advance COVID-19 vaccines and therapeutics
Deal-Making
HHS awards $1.4bn to advance COVID-19 vaccines and therapeutics
HHS awards $1.4bn to advance COVID-19 vaccines and therapeutics
Aug 24, 2023
|
2 Min Read
byMillie Nelson
CanSino and AstraZeneca form mRNA vaccine collaboration
Deal-Making
CanSino and AstraZeneca form mRNA vaccine collaboration
CanSino and AstraZeneca form mRNA vaccine collaboration
Aug 21, 2023
|
2 Min Read
byRichard Daverman
EureKING adds SCTbio to its CDMO arsenal
Deal-Making
EureKING adds SCTbio to its CDMO arsenal
EureKING adds SCTbio to its CDMO arsenal
Aug 15, 2023
|
1 Min Read
byMillie Nelson
Astellas in $50m allogeneic CAR-T deal with Poseida
Deal-Making
Astellas in $50m allogeneic CAR-T deal with Poseida
Astellas in $50m allogeneic CAR-T deal with Poseida
Aug 14, 2023
|
2 Min Read
byMillie Nelson
Regeneron bolsters hearing loss programs with Decibel buy
Deal-Making
Regeneron bolsters hearing loss programs with Decibel buy
Regeneron bolsters hearing loss programs with Decibel buy
Aug 10, 2023
|
2 Min Read
byMillie Nelson
UK consortium awarded $1m to develop iPSC platform
Deal-Making
UK consortium awarded $1m to develop iPSC platform
UK consortium awarded $1m to develop iPSC platform
Aug 9, 2023
|
2 Min Read
byMillie Nelson
Fina selects Scorpius to manufacture conjugate vaccine protein
Deal-Making
Fina selects Scorpius to manufacture conjugate vaccine protein
Fina selects Scorpius to manufacture conjugate vaccine protein
Aug 8, 2023
|
1 Min Read
byMillie Nelson
MaxCyte inks electroporation deal with Prime
Deal-Making
MaxCyte inks electroporation deal with Prime
MaxCyte inks electroporation deal with Prime
Aug 3, 2023
|
2 Min Read
byMillie Nelson
AstraZeneca ups CGT interest through $1bn Pfizer deal
Deal-Making
AstraZeneca ups CGT interest through $1bn Pfizer deal
AstraZeneca ups CGT interest through $1bn Pfizer deal
Jul 28, 2023
|
2 Min Read
byDan Stanton
MIT receives $82m from FDA for continuous mRNA manufacturing platform
Deal-Making
MIT receives $82m from FDA for continuous mRNA manufacturing platform
MIT receives $82m from FDA for continuous mRNA manufacturing platform
Jul 24, 2023
|
2 Min Read
byMillie Nelson
Novartis bolsters neuroscience pipeline with $500m DTx buy
Deal-Making
Novartis bolsters neuroscience pipeline with $500m DTx buy
Novartis bolsters neuroscience pipeline with $500m DTx buy
Jul 20, 2023
|
2 Min Read
byMillie Nelson

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Register Now: Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency
Ask the Expert webcasts
ATE Webcasts
Register Now: Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System
Register Now: Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System
Ask the Expert webcasts
ATE Webcasts
Register Now: Out of the Box Computer Software Assurance with ValGenesis VLMS
Register Now: Out of the Box Computer Software Assurance with ValGenesis VLMS
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Lonza WP
Sponsored Content
Exploring Technologies for cGMP Success with Encapsulation of Nucleic Acid-based Therapeutics
Exploring Technologies for cGMP Success with Encapsulation of Nucleic Acid-based Therapeutics

Oct 28, 2024

Repligen white paper
Sponsored Content
30% Increase in Concentration Accuracies with KrosFlo® RS 30 RPM™ TFF System
30% Increase in Concentration Accuracies with KrosFlo® RS 30 RPM™ TFF System

Oct 25, 2024

Solventum white paper
Sponsored Content
3M™ Harvest RC Centrate Chromatographic Clarifier: Evolving the Role of Clarification in the Biopharmaceutical Manufacturing Process
3M™ Harvest RC Centrate Chromatographic Clarifier: Evolving the Role of Clarification in the Biopharmaceutical Manufacturing Process

Oct 25, 2024